Prevention and treatment of cystitis during menopause: efficacy of a nutraceutical containing D-mannose, inulin, cranberry, bearberry, and .

AIM OF THE STUDY

To evaluate the efficacy of a nutraceutical compound containing Uticlin® (D-mannose, cranberry, bearberry, ), inulin, and , in preventing recurrent urinary tract infections (UTIs) in menopausal women.

MATERIAL AND METHODS

This was a prospective cohort study of menopausal women recruited with a history of recurrent UTIs in the previous twelve months and who intended to treat their bladder problem without the use of antibiotics and/or anti-inflammatories. Women were proposed the use of an oral nutraceutical compound. The drug was taken for ten days, every month. Women were assigned to two parallel cohorts: patients using (group 1) or not using (group 2) this nutraceutical compound. The primary objective of the study was to evaluate the number of women with less than two infective episodes in the 6-month follow-up and less than three episodes in the 12-month follow-up. The secondary endpoints were to evaluate the reduction of related symptoms at 12-month follow-up, according to the Visual Analog Scale (VAS).

RESULTS

At 6 months of therapy, the reduction in the number of patients with ≥ 2 UTIs was statistically significant ( < 0.05) compared to baseline only in group 1. At 12 months, the number of patients who were disease-free was significantly higher ( < 0.05) in group 1 compared to group 2. Moreover, the improvement of related symptoms was statistically significant ( < 0.05) in group 1, as shown by the reduction in the VAS scale value.

CONCLUSIONS

In menopausal women, the combination of D-mannose, inulin, cranberry, bearberry, and SGL 11 per os represents a useful therapy for recurrent UTIs in women wanting a natural approach.